Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (41-50 of 1,122) with videos related to

Pageof 113
Sort By:
Clinical Prostate Cancer|March 30, 2004
Zoledronic acid significantly reduces pathologic fractures in patients with advanced-stage prostate cancer metastatic to boneFred Saad
Cancer Treatment Reviews|May 9, 2006
Optimizing patient therapy: the role of bone markers?Fred Saad
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 18, 2013
Metastatic castration-resistant prostate cancer: The emerging continuum of careFred Saad
European Urology Focus|August 18, 2024
Should Only Patients with BRCA Mutation Be Treated with a Combination of an Androgen Receptor Pathway Inhibitor and a PARP Inhibitor for Metastatic Castration-resistant Prostate Cancer? The Answer Is NoFred Saad
Current Opinion in Supportive and Palliative Care|August 4, 2018
Improving outcome in patients with prostate and kidney cancer: heading in the right direction?Fred Saad
JAMA Oncology|May 26, 2018
Reliably Quantifying Bone Metastases in Prostate Cancer-Are We Finally There?Fred Saad
BJU International|January 22, 2009
Src as a therapeutic target in men with prostate cancer and bone metastasesFred Saad
Journal of the National Cancer Institute|September 4, 2003
Bisphosphonates in prostate cancer: where are we and where should we go?Fred Saad
BJU International|June 20, 2008
Research in genitourinary oncology: the Canadian Uro-Oncology Group multidisciplinary modelFred Saad
The Lancet. Oncology|February 5, 2019
Quality of life in men with prostate cancerFred Saad
Pageof 113

Showing results (41-50 of 1,122) with videos related to

Sort By:
Pageof 113
Clinical Prostate Cancer|March 30, 2004
Zoledronic acid significantly reduces pathologic fractures in patients with advanced-stage prostate cancer metastatic to boneFred Saad
Cancer Treatment Reviews|May 9, 2006
Optimizing patient therapy: the role of bone markers?Fred Saad
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 18, 2013
Metastatic castration-resistant prostate cancer: The emerging continuum of careFred Saad
European Urology Focus|August 18, 2024
Should Only Patients with BRCA Mutation Be Treated with a Combination of an Androgen Receptor Pathway Inhibitor and a PARP Inhibitor for Metastatic Castration-resistant Prostate Cancer? The Answer Is NoFred Saad
Current Opinion in Supportive and Palliative Care|August 4, 2018
Improving outcome in patients with prostate and kidney cancer: heading in the right direction?Fred Saad
JAMA Oncology|May 26, 2018
Reliably Quantifying Bone Metastases in Prostate Cancer-Are We Finally There?Fred Saad
BJU International|January 22, 2009
Src as a therapeutic target in men with prostate cancer and bone metastasesFred Saad
Journal of the National Cancer Institute|September 4, 2003
Bisphosphonates in prostate cancer: where are we and where should we go?Fred Saad
BJU International|June 20, 2008
Research in genitourinary oncology: the Canadian Uro-Oncology Group multidisciplinary modelFred Saad
The Lancet. Oncology|February 5, 2019
Quality of life in men with prostate cancerFred Saad
Pageof 113